- $18.90bn
- $18.90bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | 16.62 | 21.61 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
VSee Health, Inc. operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days. VSee provides patient engagement solutions, clinician staffing solutions, remote physical exam and remote patient monitoring solutions, and AI for telesitter and telenursing solutions. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions. iDoc is a provider of teleneurointensivists for neuro-critical care.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- March 30th, 2021
- Public Since
- November 4th, 2021
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Capital Market- Shares in Issue
- 15,362,278,000
- Address
- 980 N Federal Hwy, #304, BOCA RATON, 33432
- Web
- https://vsee.com/
- Phone
- +1 5616727068
- Auditors
Upcoming Events for VSEE
Vsee Health Inc Annual Shareholders Meeting
Q2 2025 Vsee Health Inc Earnings Release
Similar to VSEE
180 Life Sciences
NASDAQ Capital Market
36Kr Holdings
NASDAQ Capital Market
3 E Network Technology
NASDAQ Capital Market
A2Z Cust2mate Solutions
NASDAQ Capital Market
Abits
NASDAQ Capital Market
FAQ
What is the Vsee Health share price?
As of Today at 18:03 UTC, shares in Vsee Health are trading at $1.23. This share price information is delayed by 15 minutes.
How has the Vsee Health share price performed this year?
Shares in Vsee Health last closed at $1.23 and the price had moved by -89.75% over the past 365 days. In terms of relative price strength the Vsee Health share price has underperformed the S&P500 Index by -90.76% over the past year.
What are the analyst and broker recommendations for Vsee Health?
The overall consensus recommendation for Vsee Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Vsee Health dividend yield?
Vsee Health does not currently pay a dividend.
Does Vsee Health pay a dividend?
Vsee Health does not currently pay a dividend.
When does Vsee Health next pay dividends?
Vsee Health does not currently pay a dividend.
How do I buy Vsee Health shares?
To buy shares in Vsee Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vsee Health?
As of the previous close price of $1.23, shares in Vsee Health had a market capitalisation of $18.90bn.
Where are Vsee Health shares listed?
Here are the trading details for Vsee Health:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: VSEE
What kind of share is Vsee Health?
Based on an overall assessment of its quality, value and momentum Vsee Health is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vsee Health share price forecast for 2025?
The analyst consensus target price for shares in Vsee Health is $5.00. That is 306.5% above the last closing price of $1.23.
Analysts covering Vsee Health currently have a consensus Earnings Per Share (EPS) forecast of -$0.36 for the next financial year.
Find out moreWhat is the trend in the Vsee Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vsee Health. Over the past six months, its share price has underperformed the S&P500 Index by -17.62%.
As of the last closing price of $1.23, shares in Vsee Health were trading -25.7% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vsee Health PE Ratio?
The Vsee Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.23.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vsee Health?
We do not have data on Vsee Health's directors